![](/img/cover-not-exists.png)
DOP071 Tight control with adalimumab-based treatment is associated with improved quality of life outcomes in patients with moderate to severely active Crohn’s disease: data from CALM
Panaccione, R, Colombel, J -F, Bossuyt, P, Baert, F, Vanasek, T, Danalioglu, A, Novacek, G, Armuzzi, A, Reinisch, W, Neimark, E, Petersson, J, Robinson, A M, Thakkar, R B, Chen, N, Skup, M, Lee, W -J,Volume:
12
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx180.108
Date:
January, 2018
File:
PDF, 1.40 MB
english, 2018